¹û¶³´«Ã½

Porvair delivers record profits

There were positives to take from these results for the incoming chief executive

Amazon's guidance disappoints market

The retail and computing company is spending a lot on capex but growth is slowing.

Ashmore outflows slow as investors return to emerging markets

But the emerging markets investment manager isn’t out of the woods yet

Philip Morris bets big on smoke-free future

Early investment in non-traditional products is bearing fruit

Compass: strong early start points to another good year

Caterer reports 9 per cent organic sales growth in first quarter

AstraZeneca’s earnings ramp up

While the results showcased some of the Cambridge-based company’s problems, it was its virtues that caught the market’s attention

Alphabet earmarks $75bn for AI – can it stay ahead of DeepSeek?

Growth expectations remain high despite the emergence of a low-cost competitor on the AI front

GSK bounces back on better outlook and share buybacks

The UK pharma giant pleases the market with a solid set of results, despite uncertainty in the US

Archer Daniels Midland slashes headcount as margins contract

Near-term prospects have gone to seed as market gluts persist

Market overreacts to Vodafone update

The telecom company's share price dropped despite revealing little information that changes the story.